WebTo select the most promising chemotherapy for LAPC, a randomized phase II selection design trial (JCOG1407) was conducted to compare between modified FOLFIRINOX … Web1 ott 2024 · At this present, the superiority of the two major standard treatments is not clear, and so we conduct phase II trial (JCOG1407) which is compared GnP and mFFX for locally advanced PC and phase III trial (JCOG1611) which is compared GnP, mFFX and S-1/OX/IRI for mPC. If the first line chemotherapy changes, the secondary treatment …

Current Issue Table of Contents Journal of Clinical Oncology

Web1 ott 2024 · Protocol digest of study JCOG14072.1. Objectives. The objective of this study is to evaluate the efficacy and safety of treatment with modified FOLFIRINOX and GnP and … Web17 gen 2024 · JCOG1407: 局所進行膵癌を対象としたmodified FOLFIRINOX療法とゲムシタビン+ナブパクリタキセル併用療法のランダム化第II相試験の詳細情報です。進捗状 … david lee miller shaved head

Protocol digest of randomized phase II study of modified …

WebThe following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to … WebOral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity. Sarbani G. Laskar, Devendra Chaukar, Mandar Deshpande, Abhishek Chatterjee, ... Web1 ott 2024 · Protocol digest of study JCOG14072.1. Objectives. The objective of this study is to evaluate the efficacy and safety of treatment with modified FOLFIRINOX and GnP and to determine more promising regimen for patients with locally advanced pancreatic cancer. 2.2. Study design. Multicenter, two-arm, open-label, randomized phase II selection … gas refill witbank